345 related articles for article (PubMed ID: 27434109)
1. [Demographic characteristics, malaria chemoprophylaxis and vaccination in 6,783 international travelers attended in a specialized unit].
Jaén-Sánchez N; Suárez-Hormiga L; Carranza-Rodríguez C; Hernández-Cabrera M; Pisos-Álamo E; García-Reina L; Pérez-Arellano JL
Rev Esp Quimioter; 2016 Oct; 29(5):249-54. PubMed ID: 27434109
[TBL] [Abstract][Full Text] [Related]
2. Spanish travelers to high-risk areas in the tropics: airport survey of travel health knowledge, attitudes, and practices in vaccination and malaria prevention.
Lopez-Velez R; Bayas JM
J Travel Med; 2007; 14(5):297-305. PubMed ID: 17883460
[TBL] [Abstract][Full Text] [Related]
3. Malaria chemoprophylaxis regimens: a descriptive drug utilization study.
Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR
Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849
[TBL] [Abstract][Full Text] [Related]
4. The elderly, the young and the pregnant traveler -- A retrospective data analysis from a large Swiss Travel Center with a special focus on malaria prophylaxis and yellow fever vaccination.
Jaeger VK; Tschudi N; Rüegg R; Hatz C; Bühler S
Travel Med Infect Dis; 2015; 13(6):475-84. PubMed ID: 26526774
[TBL] [Abstract][Full Text] [Related]
5. Questionnaire-based analysis of atovaquone-proguanil compared with mefloquine in the chemoprophylaxis of malaria in non-immune Japanese travelers.
Kato T; Okuda J; Ide D; Amano K; Takei Y; Yamaguchi Y
J Infect Chemother; 2013 Feb; 19(1):20-3. PubMed ID: 22740189
[TBL] [Abstract][Full Text] [Related]
6. Compliance of Austrian tourists with prophylactic measures.
Kollaritsch H; Wiedermann G
Eur J Epidemiol; 1992 Mar; 8(2):243-51. PubMed ID: 1644143
[TBL] [Abstract][Full Text] [Related]
7. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
Overbosch D; Schilthuis H; Bienzle U; Behrens RH; Kain KC; Clarke PD; Toovey S; Knobloch J; Nothdurft HD; Shaw D; Roskell NS; Chulay JD;
Clin Infect Dis; 2001 Oct; 33(7):1015-21. PubMed ID: 11528574
[TBL] [Abstract][Full Text] [Related]
8. Vaccinations and Malaria Chemoprophylaxis of Adolescents Traveling From Greece to International Destinations: A Nine-Year Prospective Study.
Maltezou HC; Pavli A; Theodoridou K; Katerelos P; Spilioti A; Tedoma A; Lymperi I; Theodoridou M
Pediatr Infect Dis J; 2018 May; 37(5):e132-e135. PubMed ID: 28885461
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis A, typhoid and malaria among travelers--surveillance data from Québec (Canada).
Provost S; Gagnon S; Lonergan G; Bui YG; Labbé AC
J Travel Med; 2006; 13(4):219-26. PubMed ID: 16884404
[TBL] [Abstract][Full Text] [Related]
10. Drug-free Holidays: Compliance, Tolerability, and Acceptability of a 3-Day Atovaquone/Proguanil Schedule for Pretravel Malaria Chemoprophylaxis in Australian Travelers.
Lau CL; Ramsey L; Mills LC; Furuya-Kanamori L; Mills DJ
Clin Infect Dis; 2019 Jun; 69(1):137-143. PubMed ID: 30281083
[TBL] [Abstract][Full Text] [Related]
11. Malaria surveillance--United States, 2012.
Cullen KA; Arguin PM;
MMWR Surveill Summ; 2014 Dec; 63(12):1-22. PubMed ID: 25474160
[TBL] [Abstract][Full Text] [Related]
12. Imported malaria is stable from Africa but declining from Asia.
Møller CH; David K
Dan Med J; 2014 May; 61(5):A4827. PubMed ID: 24814737
[TBL] [Abstract][Full Text] [Related]
13. Review: Malaria chemoprophylaxis for travelers to Latin America.
Steinhardt LC; Magill AJ; Arguin PM
Am J Trop Med Hyg; 2011 Dec; 85(6):1015-24. PubMed ID: 22144437
[TBL] [Abstract][Full Text] [Related]
14. Vaccination and malaria prophylaxis among Greek international travelers to Asian destinations.
Pavli A; Silvestros C; Patrinos S; Maltezou HC
J Infect Public Health; 2015; 8(1):47-54. PubMed ID: 25129447
[TBL] [Abstract][Full Text] [Related]
15. Surveillance for travel-related disease--GeoSentinel Surveillance System, United States, 1997-2011.
Harvey K; Esposito DH; Han P; Kozarsky P; Freedman DO; Plier DA; Sotir MJ;
MMWR Surveill Summ; 2013 Jul; 62():1-23. PubMed ID: 23863769
[TBL] [Abstract][Full Text] [Related]
16. Malaria chemoprophylaxis: what do the travelers choose, and how does pretravel consultation influence their final decision.
Senn N; D'Acremont V; Landry P; Genton B
Am J Trop Med Hyg; 2007 Dec; 77(6):1010-4. PubMed ID: 18165513
[TBL] [Abstract][Full Text] [Related]
17. Travellers' profile, travel patterns and vaccine practices--a 10-year prospective study in a Swiss Travel Clinic.
Boubaker R; Meige P; Mialet C; Buffat CN; Uwanyiligira M; Widmer F; Rochat J; Fossati AH; Souvannaraj-Blanchant M; Payot S; Rochat L; de Vallière S; Genton B; D'Acremont V
J Travel Med; 2016 Jan; 23(1):. PubMed ID: 26792229
[TBL] [Abstract][Full Text] [Related]
18. Malaria Disease and Chemoprophylaxis Usage among Israeli Travelers to Endemic Countries.
Harel R; Chazan B; Schwartz E
Am J Trop Med Hyg; 2020 Jun; 102(6):1351-1357. PubMed ID: 32274987
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of short prophylactic course of atovaquone-proguanil in travelers to sub-saharan Africa.
Leshem E; Meltzer E; Stienlauf S; Kopel E; Schwartz E
J Travel Med; 2014; 21(2):82-5. PubMed ID: 24298915
[TBL] [Abstract][Full Text] [Related]
20. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study.
Camus D; Djossou F; Schilthuis HJ; Høgh B; Dutoit E; Malvy D; Roskell NS; Hedgley C; De Boever EH; Miller GB;
Clin Infect Dis; 2004 Jun; 38(12):1716-23. PubMed ID: 15227617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
